Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273858
Status:
TERMINATED
Last Update Posted:
2011-09-12
First Post:
2006-01-04
Brief Title:
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis Ankylosing Spondylitis and Psoriatic Arthritis
Sponsor:
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
880
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 1727 |
Who Masked List: